Please join us for the HPS Corporate Lending Fund First Quarter 2026 Shareholder Update Webcast

Portfolio

HLEND seeks to build a diversified portfolio of senior secured private credit investments in resilient, market-leading, upper-middle market companies that operate primarily in non-cyclical sectors.

Data as of March 31, 2026

$25.0B

Investments at Fair Value

9.3%

Portfolio Yield at Fair Value1

94%

Private Investments2

95%

First Lien Exposure3

99%

Floating Rate4

$255M

Weighted Average EBITDA5

Portfolio Companies89

Clear Filters
Company Name
Industry
Investment Type
Reference Rate & Spread11
Par Amount (thousands)
Amortized Cost (thousands)
Fair Value (thousands)
% of Total Portfolio
Artifact Bidco, Inc. (Avetta, LLC) Software S + 4.15% $65,000 45,284 45,788 0.18%
Artisan Bidco, Inc. (Avid Technology, Inc.) Software S + 7.00% $46,088 43,904 42,464 0.17%
Artisan Bidco, Inc. (Avid Technology, Inc.) Software E + 7.00% €18,195 19,170 19,981 0.08%
Aryeh Bidco Investment Ltd (DENTAL CORP OF CANADA) Health Care Providers & Services CORRA + 5.00% CAD 241,650 133,709 133,410 0.53%
Ascensus Holdings, Inc. (AqGen Ascensus, Inc.) Financial Services S + 3.00% $14,005 13,972 13,804 0.06%
Aspen Dental Management Inc. (ADMI Corp) (Aspen Dental Management Inc.) Health Care Providers & Services S + 5.75% $843 847 808 0.00%
Aspen Dental Management Inc. (ADMI Corp) (Aspen Dental Management Inc.) Health Care Providers & Services S + 3.75% $3,259 3,227 3,065 0.01%
Aspire Bakeries Holdings LLC (Aspire Bakeries) Food Products S + 3.00% $9,442 9,414 9,466 0.04%
Associations Finance, Inc. (Associations Inc.) Real Estate Management & Development 14.25% PIK $14,754 14,716 14,754 0.06%
Associations Inc. Real Estate Management & Development S + 6.50% $62,609 56,876 56,910 0.23%
AthenaHealth Group Inc. (AthenaHealth) Health Care Technology S + 2.75% $17,994 17,876 17,690 0.07%
Atlas Borrower, LLC (AnovoRx) Pharmaceuticals S + 4.50% $103,246 87,063 86,635 0.35%
Atlas Intermediate III LLC (Actylis) Trading Companies & Distributors S + 7.75% $134,971 119,652 116,360 0.47%
Auctane Inc (Stamps.com Inc.) Broadline Retail S + 5.75% $24,250 24,250 23,948 0.10%
Auditboard, Inc. Software S + 4.75% $30,286 -229 -600 0.00%
Auditboard, Inc. Software S + 4.50% $244,465 242,554 239,625 0.96%
Aurelia Netherlands Midco 2 B.V. (Adevinta ASA) Interactive Media & Services E + 4.75% €125,373 137,868 144,313 0.58%
Avalara, Inc. (Avalara) Software S + 2.75% $13,259 13,196 12,977 0.05%
Aventine Intermediate LLC (Blackstone Media) Entertainment S + 6.00% (incl 3.50% PIK) $12,393 12,328 11,090 0.04%
Axiom Buyer, LLC (Axiom) Commercial Services & Supplies S + 6.50% $182,453 157,867 158,442 0.63%
Azalea Topco, Inc. (Press Ganey) Health Care Technology S + 3.00% $11,829 11,764 11,825 0.05%
Azurity Pharmaceuticals Inc (Azurity Pharmaceuticals) Pharmaceuticals S + 7.00% $250,486 246,526 243,345 0.97%
BCPE Virginia Holdco, Inc. (Guidehouse Inc.) Professional Services 13.75% Preferred Return $2,000 1,960 2,783 0.01%
BLY US Holdings Inc. (Boart Longyear Management) Metals & Mining S + 6.00% $71,641 70,429 69,987 0.28%
BMC Software Inc. (BMC Software) Software S + 3.00% $2,970 2,941 2,762 0.01%

Engage with HLEND

Start Here

Footnotes

  1. Computed as (a) the annual stated interest rate or yield plus the annual accretion of discounts and less any annual amortization of premiums, as applicable, on accruing (i) debt and (ii) other income producing securities, divided by (b) total accruing (i) debt and (ii) other income producing securities (at fair value). Actual yields earned over the life of each investment could differ materially from the yields presented above. Please refer to HLEND’s prospectus and filings, including Form 10-Q or Form 10-K for fair value disclosures.
  2. Private Investments represents level 3 investments in the investment portfolio where inputs to the valuation methodology are unobservable and significant to overall fair value measurement. Private investments includes investments in joint ventures.
  3. Based on the aggregate fair value of the investment portfolio as of March 31, 2026.
  4. Percentage based on aggregate fair value of accruing debt.
  5. Calculated with respect to all level 3 investments (or, with respect to weighted average loan to value, all level 3 debt investments) in the investment portfolio for which fair value is determined by the Investment Adviser (in its capacity as the investment adviser of HLEND, with assistance, at least quarterly, from a third-party valuation firm, and overseen by HLEND’s Board of Trustees), and excludes quoted assets and investments in joint ventures. In the case of weighted average EBITDA only, excludes investments with no reported EBITDA or where EBITDA, in the Investment Adviser’s judgement made in its discretion, was not a material component of the original investment thesis, such as loan-to-value-based loans, NAV-based loans or reorganized equity. Weighted average EBITDA is weighted based on the fair value of the total applicable level 3 investments. Loan to value is calculated as net debt through each respective investment tranche in which HLEND holds an investment divided by enterprise value or value of underlying collateral of the portfolio company. Weighted average loan to value is weighted based on the fair value of the total applicable level 3 debt investments. Excludes investments on non-accrual status as of October 31, 2024. Figures are derived from the most recent financial statements from portfolio companies.
  6. Includes “last out” portions of first lien senior secured loans.
  7. Secured debt at the holding company level.
  8. Based on MSCI / S&P Global Industry Classification Standard (“GICS”) industry definition. Totals may not sum due to rounding. 
  9. All figures are as of March 31, 2026 unless otherwise indicated. % of total portfolio shown above is measured as total fair value of investments.
  10. Other includes structured finance investments.
  11. Contractual rates on preferred equity investments may represent preference accruals that are not recognized through investment income of the fund and as such are not included in the calculation of yield. The fair value of these investments may be influenced by the stated preference accrual or a minimum return threshold.